Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV) and AbbVie (ABBV)

US takes next step in Medicare drug price negotiations with pharma companies

US takes next step in Medicare drug price negotiations with pharma companies

NEXGEL, Inc. (NASDAQ:NXGL) Q4 2023 Earnings Call Transcript

Roivant's anti-inflammatory drug succeeds in mid-stage study

Got $3,000? 2 Monster Growth Stocks to Buy Right Now Without Hesitation

AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know

AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study

How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

This Biopharma Stock Outperforms MSTR and SMCI in March 2024

3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade

Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs

Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs

Here are Thursday's biggest analyst calls: Nvidia, Meta, Tesla, Apple, CyberArk, Grindr, Estee Lauder & more

Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?

Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?

Long Live the Dividend Kings: 3 Top Picks to Build an Income Portfolio